Fast Five Quiz: HIV Pre-exposure Prophylaxis: Selecting Appropriate Candidates

Jason F. Okulicz, MD


June 09, 2022

Figure 1. A scanning electron microscopic image of HIV. The glycoprotein complex on its surface enables the virus to attach to and fuse with target cells to initiate the infectious cycle.

HIV PrEP is recommended for all HIV-negative individuals at risk of acquiring HIV through sex or injection drug use. PrEP may be considered in any HIV-negative person who requests it, including those who do not report at-risk behavior and adolescents and young adults weighing at least 77 lb (35 kg).

Currently, the FDA has approved two oral drugs for PrEP, each taken as a single tablet daily, and an injectable drug given every 2 months.

Learn more about selecting candidates for HIV PrEP.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.